Timothy Daley
Stock Analyst at Wells Fargo
(2.06)
# 2,920
Out of 4,944 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $49.23 | -5.18% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $5.87 | +240.72% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $90.93 | +4.48% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $34.54 | +108.45% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $120.29 | +20.54% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,324.06 | -1.82% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $296.83 | -3.99% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $209.14 | +18.10% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $155.00 | +77.42% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $272.54 | -0.93% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $5.54 | +405.42% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $22.36 | +56.53% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $484.79 | +7.26% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $1.98 | +354.55% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $127.15 | +45.50% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $68.98 | +23.22% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $190.23 | +15.65% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $176.29 | +24.79% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $13.07 | +114.23% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $179.04 | -21.81% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $54.71 | +64.50% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $49.23
Upside: -5.18%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $5.87
Upside: +240.72%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $90.93
Upside: +4.48%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $34.54
Upside: +108.45%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $120.29
Upside: +20.54%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,324.06
Upside: -1.82%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $296.83
Upside: -3.99%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $209.14
Upside: +18.10%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $155.00
Upside: +77.42%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $272.54
Upside: -0.93%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $5.54
Upside: +405.42%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $22.36
Upside: +56.53%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $484.79
Upside: +7.26%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $1.98
Upside: +354.55%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $127.15
Upside: +45.50%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $68.98
Upside: +23.22%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $190.23
Upside: +15.65%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $176.29
Upside: +24.79%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $13.07
Upside: +114.23%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $179.04
Upside: -21.81%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $54.71
Upside: +64.50%